Inner Mongolia Furui Medical Science Co Ltd
SZSE:300049
Inner Mongolia Furui Medical Science Co Ltd
Revenue
Inner Mongolia Furui Medical Science Co Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
I
|
Inner Mongolia Furui Medical Science Co Ltd
SZSE:300049
|
Revenue
¥1B
|
CAGR 3-Years
7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Revenue
¥10.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Revenue
¥9.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
16%
|
CAGR 10-Years
22%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Revenue
¥22.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Revenue
¥39.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Revenue
¥2.5B
|
CAGR 3-Years
24%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
See Also
What is Inner Mongolia Furui Medical Science Co Ltd's Revenue?
Revenue
1B
CNY
Based on the financial report for Mar 31, 2023, Inner Mongolia Furui Medical Science Co Ltd's Revenue amounts to 1B CNY.
What is Inner Mongolia Furui Medical Science Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
9%
Over the last year, the Revenue growth was 12%. The average annual Revenue growth rates for Inner Mongolia Furui Medical Science Co Ltd have been 7% over the past three years , 4% over the past five years , and 9% over the past ten years .